Reading Time: 2 minutesFollowing on from baking, and understanding the roles of genes and proteins, Helena Chaytow (Royal Holloway) explains about her research. Helena is an MND Association-funded
Category: Treatments
Reading Time: 4 minutesThe top-line results from the Cytokinetics Inc Phase IIb clinical trial of Tirasemtiv were announced last week. Following this announcement, detailed results were then presented
Reading Time: 2 minutesA lot has been happening in terms of research policy at the moment, from the announcement of the European adaptive licensing pilot to the Government’s Early Access to
Reading Time: 4 minutesDr Jakub Scaber from the University of Oxford is our newest Medical Research Council (MRC)/ MND Association Lady Edith Wolfson Clinical Research Fellow. He is investigating
Reading Time: 4 minutesMND Association-funded researcher, Prof Linda Greensmith, based at University College London, together with her collaborator Dr Ivo Lieberam from Kings College London, have introduced stem
Reading Time: 5 minutesVictoria Pugh is studying for her PhD at the Universities of Bradford and Reading, which is funded by the MND Association. Under the leadership of Prof
Reading Time: 3 minutesAfter we posted yesterday’s blog (Thursday 10 October) about Giovanna Mallucci’s research in Leicester, we received a report on the story from the President of the
Reading Time: 4 minutesThe only ‘proven’ treatment to slow the progression of MND is Riluzole. There are, however, many organisations offering expensive ‘unproven’ and ‘alternative’ treatments for MND.
Reading Time: 4 minutesAfter a brilliant first day at ENCALS, which included a talk by Dr Johannes Brettschneider, the second day began with a talk by Thierry Latran
Reading Time: 2 minutesThe National Institute for Health Research (NIHR) has launched their ‘It’s OK to ask campaign’ which encourages patients and the public to ask about clinical research.